四川成渝高速公路(00107.HK)聘任李文虎為副董事長及總經理
格隆匯 7 月 27日丨四川成渝高速公路(00107.HK)宣佈,甘勇義因公司經營管理工作需要及相關工作變動原因而辭任公司總經理的職務,自2020年7月27日起生效。於彼辭任後,甘勇義仍在公司擔任執行董事及董事長。
同時宣佈,根據公司經營管理工作需要,於2020年7月27日,公司董事會審議同意聘任李文虎為公司第七屆董事會副董事長及公司總經理,任期自董事會決議通過之日起至公司第七屆董事會屆滿之日止。任期屆滿,可連選連任。李文虎(為公司非執行董事之一)同時獲轉任為公司的執行董事,自2020年7月27日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.